Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T16:49:13.413Z Has data issue: false hasContentIssue false
  • English
  • Français

Out-patients' perceptions of the clinical and psychosocial effects of neuroleptic medication

Published online by Cambridge University Press:  02 January 2018

Tom Chapman  and
Eric Mulvihill
Eric Mulvihill
Affiliation:
Department of Sociology and Anthropology, University of Salford
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

While research into the effectiveness of neuroleptic medication consistently demonstrates its value in improving psychotic symptoms, and in the prevention of relapse, the treatment continues to generate controversy. Indeed, McClelland (1989) has recently asserted that this treatment of choice is “an indispensable evil”; “indispensable” by virtue of its clinical effectiveness, and “evil” because of the wide range of adverse and distressing side effects experienced by patients.

Type
Articles
Information
Psychiatric Bulletin , Volume 14 , Issue 6 , June 1990 , pp. 331 - 332
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1990

References

Gardos, G. & Cole, J. (1976) Maintenance antipsychotic therapy: Is the cure worse than the disease? American Journal of Psychiatry, 133, 32–36.Google ScholarPubMed
Hogarty, G. E. et al (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. Archives of General Psychiatry, 31, 603–608.CrossRefGoogle ScholarPubMed
McClelland, H. A. (1989) Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients: Comment. British Journal of Psychiatry, 155, 702–703.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.